U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
150541150541Adding Lomustine to Chemotherapy in Older Patients With Acute Myelogenous Leukemia (AML), and Allogeneic Transplantation for Patients From 60 to 65 Years OldCompletedNo Results AvailableAcute Myeloid LeukemiaDrug: Lomustinehttps://ClinicalTrials.gov/show/NCT00590837
150542150542Pilot hu14.18-IL2 in Resectable Recurrent Stage III or Stage IV MelanomaActive, not recruitingNo Results AvailableMelanomaDrug: hu14.18-IL2|Drug: hu14.18-IL2https://ClinicalTrials.gov/show/NCT00590824
150543150543Prevalence of Menstrual Cycle Related Pain Complains in Adolescents and Young AdultsCompletedNo Results AvailableDysmenorrhea|Pelvic Painhttps://ClinicalTrials.gov/show/NCT00590811
150544150544Star-Close Early Ambulation TrialCompletedNo Results AvailableCardiovascular DiseaseBehavioral: Walkinghttps://ClinicalTrials.gov/show/NCT00590798
150545150545Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394)Active, not recruitingNo Results AvailableHigh Risk|Breast Cancer|Positive Nodes|Cyclophosphamide|DoxorubicinDrug: Doxorubicin|Drug: Cyclophosphamide|Drug: G-CSF|Drug: tamoxifen|Drug: ciprofloxacinhttps://ClinicalTrials.gov/show/NCT00590785
150546150546The Role of Montelukast in Rhinitis and SleepCompletedHas ResultsPerennial Allergic RhinitisDrug: montelukast|Drug: placebohttps://ClinicalTrials.gov/show/NCT00590772
150547150547Evaluation of the GORE TAG Thoracic Endoprosthesis in the Treatment of AneurysmsCompletedHas ResultsAortic Aneurysm, ThoracicDevice: GORE TAG® Thoracic Endoprosthesishttps://ClinicalTrials.gov/show/NCT00590759
150548150548Bedside Assessment of Fall Risk in Emergency Department EldersCompletedNo Results AvailableAccidental Fallshttps://ClinicalTrials.gov/show/NCT00590746
150549150549A Phase 2A Study to Evaluate the Safety and Effect on Exercise Challenge Testing of MEDI-528 in Adults With AsthmaTerminatedHas ResultsAsthmaBiological: MEDI528 50 mg|Other: PLACEBOhttps://ClinicalTrials.gov/show/NCT00590720
150550150550Post-Operative Delirium in Elderly Surgical PatientsRecruitingNo Results AvailableHip Fractures|DeliriumDevice: Maintenance of level of awareness by use of a BIS monitor & the OASS.|Device: Maintenance of level of awareness by use of a BIS monitor and the OASS.https://ClinicalTrials.gov/show/NCT00590707
150551150551Lucentis for Age-related Macular Degeneration Pigment Epithelial DetachmentsCompletedNo Results AvailableAge-related Macular Degeneration|Pigment Epithelial Detachment|Neovascular Macular Degeneration|Wet Macular DegenerationDrug: ranibizumabhttps://ClinicalTrials.gov/show/NCT00590694
150552150552Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma MultiformeCompletedNo Results AvailableGlioblastoma MultiformeDrug: Bevacizumab and Temozolomidehttps://ClinicalTrials.gov/show/NCT00590681
150553150553Safety Monitoring of Patients Having Pulmonary Vein AblationRecruitingNo Results AvailableAtrial Fibrillationhttps://ClinicalTrials.gov/show/NCT00590668
150554150554Maintenance Programme After Weight LossCompletedNo Results AvailableWeight Loss|Morbid ObesityBehavioral: weight loss programme with maintenance programme|Behavioral: weight loss programmehttps://ClinicalTrials.gov/show/NCT00590655
150555150555Augmentation in Tx-resistant OCD: an Open Label TrialCompletedNo Results AvailableObsessive Compulsive Disorderhttps://ClinicalTrials.gov/show/NCT00590642
150556150556Benefit of Elevation of HDL-C on Cardiovascular Outcomes in WomenCompletedNo Results AvailableCoronary Artery DiseaseDrug: Niaspanhttps://ClinicalTrials.gov/show/NCT00590629
150557150557Utility of Clinical Examination in the Noninvasive Prediction of Aortic Atheroma - A Prospective StudyCompletedNo Results AvailableAtherosclerosisProcedure: transthoracic examinationhttps://ClinicalTrials.gov/show/NCT00590616
150558150558Trisenox, Ascorbic Acid and Bortezomib in Patients With Relapsed/Refractory Multiple MyelomaTerminatedNo Results AvailableMultiple MyelomaDrug: Arsenic Trioxide, Ascorbic Acid and Bortezomibhttps://ClinicalTrials.gov/show/NCT00590603
150559150559Safety and Efficacy of Two Vaginal Products Versus Placebo in Patients With Vaginal DiscomfortCompletedHas ResultsVulvodyniaDrug: Lidocaine/Diphenhydramine|Drug: lidocaine|Drug: placebohttps://ClinicalTrials.gov/show/NCT00590590
150560150560Effectiveness and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Patients With SchizophreniaCompletedHas ResultsSchizophreniaDrug: Paliperidone palmitate 25 mg eq.|Drug: Paliperidone palmitate 150 mg eq.|Drug: Placebo|Drug: Paliperidone palmitate 100 mg eq.https://ClinicalTrials.gov/show/NCT00590577
150561150561SHO-SAIKO-TO for Patients With Chronic Hepatitis C: A Phase II StudyCompletedNo Results AvailableHepatitis CDrug: Sho-saiko-tohttps://ClinicalTrials.gov/show/NCT00590564
150562150562Slings and Their Effect on Skin PressureTerminatedNo Results AvailableWoundsOther: sling or no slinghttps://ClinicalTrials.gov/show/NCT00590551
150563150563Phenylbutyrate/Genistein Duotherapy in Delta F508-Heterozygotes (for Cystic Fibrosis)TerminatedHas ResultsCystic FibrosisDrug: Sodium 4-Phenylbutyrate|Drug: Genistein (Unconjugated Isoflavones 100)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00590538
150564150564Inflammation as a Predictor in Cardioversion of Atrial FibrillationCompletedNo Results AvailableAtrial FibrillationProcedure: Cardioversionhttps://ClinicalTrials.gov/show/NCT00590525
150565150565Dietary Salt Intake and Vascular FunctionCompletedNo Results AvailableHealthyDietary Supplement: High sodium|Dietary Supplement: Low sodiumhttps://ClinicalTrials.gov/show/NCT00590512
150566150566Agitation in Post Operative Neurosurgical PatientsCompletedNo Results AvailableAgitation|Craniotomyhttps://ClinicalTrials.gov/show/NCT00590499
150567150567Sacral Neuromodulation in Patients With ICRecruitingNo Results AvailableInterstitial CystitisDevice: Interstimhttps://ClinicalTrials.gov/show/NCT00590473
150568150568Antibody Conditioning Regimen For Allogeneic Donor Stem Cell Transplantation Of Patients With Fanconi AnemiaTerminatedHas ResultsFanconi Anemia|Severe Aplastic AnemiaBiological: CAMPATH-1H|Biological: Anti-CD45|Drug: Fludarabine|Procedure: Stem cell infusionhttps://ClinicalTrials.gov/show/NCT00590460
150569150569Risk Stratified Sequential Treatment for CD20-positive PTLDActive, not recruitingNo Results AvailablePTLD|Posttransplant Lymphoproliferative DisorderDrug: rituximab monotherapy|Drug: sequential R-CHOPhttps://ClinicalTrials.gov/show/NCT00590447
150570150570Yield and Safety of Colonoscopy in Patients Older Than 80 YearsCompletedNo Results AvailableColorectal Neoplasmshttps://ClinicalTrials.gov/show/NCT00590434

* Görseller ve İçerik tekif hakkına sahip olabilir